Skip to content
10-K

Annual Report

JINZANGHUANG TIBET PHARMACEUTICALS, INC.

0001096906-12-002472

← back to feed
Filed
Sep 28, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Sep 28, 2012 50.67M sh
Capex FY 2012 · Jun 30, 2012 $3.32K
Capex FY 2012 · Jun 30, 2011 $12.63K
Operating Cash Flow FY 2012 · Jun 30, 2012 $6.07M
Operating Cash Flow FY 2012 · Jun 30, 2011 $2.07M
Stockholders Equity FY 2012 · Jun 30, 2012 $8.99M
Stockholders Equity FY 2012 · Jun 30, 2011 $3.05M
Stockholders Equity FY 2012 · Jun 30, 2010 $1.25M
Total Liabilities FY 2012 · Jun 30, 2012 $632.3K
Total Liabilities FY 2012 · Jun 30, 2011 $562.42K
Current Assets FY 2012 · Jun 30, 2012 $9.5M
Current Assets FY 2012 · Jun 30, 2011 $3.18M
Total Assets FY 2012 · Jun 30, 2012 $10.09M
Total Assets FY 2012 · Jun 30, 2011 $3.77M
Sga Expense FY 2012 · Jun 30, 2012 $353.93K
Sga Expense FY 2012 · Jun 30, 2011 $142.55K
Net Income FY 2012 · Jun 30, 2012 $5.85M
Net Income FY 2012 · Jun 30, 2011 $1.77M
Operating Income FY 2012 · Jun 30, 2012 $8.08M
Operating Income FY 2012 · Jun 30, 2011 $2.57M
Gross Profit FY 2012 · Jun 30, 2012 $8.43M
Gross Profit FY 2012 · Jun 30, 2011 $3M
Cost Of Revenue FY 2012 · Jun 30, 2012 $2.22M
Cost Of Revenue FY 2012 · Jun 30, 2011 $720.31K